Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Amedisys Q4 2023 Adj EPS $0.94 Misses $1.03 Estimate, Sales $570.80M Beat $567.71M Estimate

Author: Benzinga Newsdesk | February 21, 2024 06:09pm
Amedisys (NASDAQ:AMED) reported quarterly earnings of $0.94 per share which missed the analyst consensus estimate of $1.03 by 8.74 percent. The company reported quarterly sales of $570.80 million which beat the analyst consensus estimate of $567.71 million by 0.54 percent. This is a 1.55 percent increase over sales of $562.06 million the same period last year.

Posted In: AMED


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist